Sushil Patel

Chief Executive Officer, Director, Replimune Group, Inc.; Director, Revolution Medicines, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.9M

Companies

Latest trade

Aug 10, 2026

Companies

Replimune Group, Inc.Chief Executive Officer, Director −$0.8M Revolution Medicines, Inc.Director −$1.0M

Trades

REPL Sold 39,341 shares at $12.97 $0.5M Aug 10

RVMD Sold 5,580 shares at $187.99 · planned $1.0M Jun 29

REPL Sold 37,324 shares at $5.08 $0.2M May 18

REPL Sold 10,000 shares at $11.13 · planned $0.1M Dec 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.